02329 GLORY HEALTH
- 0.100
- -0.012-10.71%
GLORY HEALTH News
Glory Health Auditor Resigns Amid Resource Issues
Glory Health Industry Reveals Board and Committees
Glory Health Industry Announces Leadership Change
Glory Health (02329): Yuan Hao appointed as an independent non-executive director.
Glory Health (02329) announced that Mr. Yuan Hao was appointed as an independent non-executive director of the company, as well as appointed as a public...
Glory Health Appoints New Share Registrar
Glory Health Industry Enters Cooperation Contract With Computershare Hong Kong Investor Services
Glory Health (02329) has signed a cooperation agreement with Hong Kong Central Securities Registration.
Glory Health (02329) announced that the company has completed the contract signing with Hong Kong Central Securities Registration Limited. Public...
GLORY HEALTH: Interim Report 2024
Glory Health [02329] is now trading at HK$0.1, with a decrease of 14.53%.
As of 10:21, glory health [02329] reported 0.1 Hong Kong dollars, a decrease of 0.017 Hong Kong dollars or 14.53% from the previous closing price of 0.117 Hong Kong dollars, with a turnover of 0.0208 million Hong Kong dollars. The highest price today is 0.101 Hong Kong dollars, the lowest price is 0.1 Hong Kong dollars. Based on the previous closing price, the 10-day average price is 0.12 Hong Kong dollars, the 50-day average price is 0.05 Hong Kong dollars, and the current PE ratio is -1.07 times. The 14-day relative strength index is 71.31.
Glory Health (02329) announced its interim performance, with a shareholder attributable loss of 58.659 million yuan, a year-on-year narrowing of 78.02%.
Glory Health (02329) announced its interim performance for the six months ending June 30, 2024, with total revenue of 9.87...
Express News | Glory Health Industry H1 Gross Profit RMB 432.3 Million
Express News | Glory Health Industry H1 Revenue RMB 987.5 Million
GLORY HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
Glory Health (02329) clarifies: the agreement between the company and Hong Kong Securities Registration Limited Hong Kong Stock Transfer Registry has been terminated on August 19.
Glory Health (02329) issued a clarification, the company and the Hong Kong Share Transfer Registry of the Hong Kong Central Securities Registration Company...
Glory Health Faces Potential Trading Suspension
Express News | Glory Health Industry - Received Notice From Exchange Dealing in Company's Shares Will Be Suspended on 19 Nov
Glory Health (02329.HK) held a board of directors meeting on August 30 to consider and approve the semi-annual performance.
Glory Health (02329.HK) announced on August 16th that the company will hold a board of directors meeting on August 30th, 2024 (Friday) to consider and approve the unaudited semi-annual performance of the company and its subsidiaries as of June 30th, 2024, and to consider recommending the distribution of dividends (if any).
Glory Health Industry Schedules Financial Review Meeting
Glory Health (02329) signs a letter of intent for strategic cooperation with China Health.
Glory Health (02329) announced that the company has recently entered into an agreement with China Healthcare Investment Fund Management Co., Ltd. ...
Express News | Glory Health Industry - Signed Strategic Cooperation Letter of Intent With China Health Industry Investment Fund Management
Analysis
Price Target
No Data
No Data